Resin-modified glass ionomer cement (RMGIC) is considered a fluoride-releasing bonding agent. The aim of the study was to evaluate the rate of bracket bond failure with light-cured composite (LCC) and RMGIC, and to evaluate factors that contribute to the rate of bracket failure with both bonding agents. A randomized controlled trial was conducted on a sample size of 33 patients. The patients were randomly allocated for bonding with visible LCC (control group) or RMGIC (intervention group) using the lottery method. The study was double-blinded. The rate of bracket bond failure was assessed after a follow-up of minimum 3 months and evaluated using the survival regression analysis, taking into account the effects of bonding agents and other factors influencing bracket bond failure. A total of 33 participants were recruited for the study, and 66 quadrants for the intervention and control groups were randomly selected and analyzed. The data was normally distributed and the mean age of the subjects was comparable between both bonding systems. The results of the regression analysis indicated that there was no statistically significant difference between the rate of bracket bond failure with RMGIC and LCC (p = 0.081). However, after analyzing the mean days of survival, it was found that bracket survival was negligibly low with RMGIC, with a mean of 216.00 ±133.72 days as compared to LCC, with a mean survival of 224.11 ±124.59 days. No adverse effects were observed during the course of the trial. There was no difference in the rate of bracket bond failure between the intervention and control groups. The survival rate of brackets treated with RMGIC was found to be comparable to that of LCC, with a minimal difference.
Read full abstract